Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience. April 09, 2021

Demand For Life Science Real Estate Shows No Sign Of Slowing

As demand for life science centers continues growing, U.S. metros are avidly vying for life-science prominence, with Charleston, Columbus and Houston all emerging as fast-rising contenders.
Read by 35% of LPs March 31, 2021

Healthcare & Life Sciences Private Equity Deal Tracker: Northlane Capital Invests In Empower Community Care | Mcguirewoods Llp

Northlane Capital Partners (NCP) has announced it has completed an investment in Empower Community Care....By: McGuireWoods LLP. : Northlane Capital Partners (NCP) has announced it has completed an investment in Empower Community Care. Empower, based in Atlanta, is a behavioral health organization that distributes evidence-based programs and technologies. The company provides services in 45 states and 17 countries. Empower is the parent company of MST Services, Orbis Partners and Evidence Based Associates. NCP, based in Bethesda, Md., is a middle market private equity firm focused on healthcare and business services.
Read by 53% of LPs March 11, 2021

Healthcare & Life Sciences Private Equity Deal Tracker: Platinum Equity Acquires Ndc From Court Square Capital Partners | Mcguirewoods Llp

Platinum Equity has acquired NDC from an affiliate of Court Square Capital Partners, according to a news release....By: McGuireWoods LLP.
Read by 33% of LPs February 22, 2021

Medibuddy Raises $20mn Funding From India Life Sciences Fund Iii, Others | Business Standard News

The firm raised $20 million (about Rs 145 crore) earlier this month from India Life Sciences Fund III, LLC and others.
Read by 61% of LPs February 16, 2021

3 Top Life Science Vcs: Why Covid-19 Won't Reshape The Drug Industry

Summary List PlacementTake all venture capital predictions with a grain of salt, Venrock partner Cami Samuel told Insider. Though Andreessen Horowitz may have predicted a flood of investment dollars in infectious diseases in 2021 inspired by the pandemic in its start-of-year blog post, the early-stage biotech VC is sticking to her guns. Last March, Samuels told TechCrunch that the pandemic likely wouldn't drastically increase investors' interest in infectious diseases. Almost a year later, Samuels told Insider her stance hasn't changed.
Read by 79% of LPs February 15, 2021

Woodford Returns With New Firm Targeting Acacia Life Sciences Portfolio

Neil Woodford has returned 16 months after the collapse of Woodford Investment Management with the launch of a new investment firm, which is working alongside Acacia Research to "advise" on an illiquid and unlisted portfolio of life sciences companies once owned by the Woodford Equity Income fund (WEIF).
Read by 72% of LPs January 05, 2021

Healthcare & Life Sciences Private Equity Deal Tracker: H.i.g. Capital Acquires Crothall Laundry Services | Mcguirewoods Llp

H.I.G. Capital has announced it has completed its acquisition of Crothall Laundry Services....By: McGuireWoods LLP. : Crothall Laundry Services is a provider of outsourced laundry and linen management services to the healthcare and hospitality markets. Founded in 1991, the company is formerly a Compass Group subsidiary. H.I.G. Capital, based in Miami, pursues a wide range of investments in healthcare and many other industries. Founded in 1993, the firm has flexibility on investment size, including interest in pre-EBITDA businesses. Within healthcare, the firm targets companies in the provider services, hospital/major facilities and life sciences/pharmaceutical industries.
Read by 39% of LPs December 15, 2020

Nference Completes $60M Series C To Accelerate And Expand Augmented Intelligence For Life Sciences

CAMBRIDGE, Mass., December 15, 2020-- nference, which synthesizes the world's biomedical knowledge, announced completion of a $60 million Series C funding round led by Matrix Capital Management, along with Matrix Partners, Mayo Clinic Ventures and NTTVC. "nference - a science-first software company - continues to push the boundaries of augmented intelligence to accelerate the work of our expert scientists and technologists in making biomedical knowledge computable via our nferXTM software platform," said Murali Aravamudan, co-founder and chief executive officer. "This funding enables expansion of our portfolio, which is catalyzing development of meaningful diagnostics and therapeutics.
Read by 76% of LPs December 07, 2020

Healthcare & Life Sciences Private Equity Deal Tracker: Serent Capital Invests In Procurement Partners | Mcguirewoods Llp

Serent Capital has completed a growth investment in Procurement Partners, according to a news release. Procurement Partners, based in Brookfield, Wis., is a provider of procure-to-pay solutions for healthcare providers....By: McGuireWoods LLP.
Read by 40% of LPs December 03, 2020

Rubedo Life Sciences Closes $12M Seed Financing Led By Khosla Ventures

- Company optimizing lead compounds to file IND application and initiate first-in-human clinical trials targeting senescent cells in pulmonary disorders - Funding will be used to drive R&D, advance clinical pipeline and expand scientific team SUNNYVALE, Calif., December 3, 2020-- Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today announced the closing of a $12M Seed financing round. The round was led by Khosla Ventures, with participation from Longevity Fund, Refactor Capital, Shanda and additional investors.
Read by 41% of LPs